ArticleFrontiers in immunology2023

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells.

Xinlin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.